Characteristic | Overall (n = 676) | 3GC-susceptible (n = 543) | 3GC-resistant (n = 133) |
---|---|---|---|
Age, years, mean ± SD | 67.1 ± 15.5 | 66.8 ± 15.5 | 68.0 ± 15.2 |
Sex, femalea | 419 (62.0) | 347 (63.9) | 72 (54.1) |
Hospitalization within the past 1 yeara | 305 (45.1) | 215 (39.6) | 90 (67.7) |
Exposure to antibiotics within the past 15 daysa | 55 (8.2) | 32 (5.9) | 23 (17.3) |
Medical facility utilizationa: | |||
 OPD for hypertension/ diabetes mellitus | 473 (70.0) | 373 (68.7) | 100 (75.2) |
 OPD for chemotherapy | 95 (14.0) | 65 (12.0) | 30 (22.6) |
 Hemodialysis or peritoneal dialysis | 24 (3.6) | 14 (2.6) | 10 (7.5) |
 Nursing home/Long-term care facility | 12 (1.8) | 6 (1.1) | 6 (4.5) |
Charlson comorbidity index, median (range) | 2 (0–13) | 2 (0–11) | 3 (0–13) |
Indwelling mucosal cathetera | 129 (19.1) | 84 (15.5) | 45 (33.8) |
Indwelling intravenous cathetera | 100 (14.8) | 64 (11.8) | 36 (27.1) |
Primary focusa: | |||
 Primary bacteremia | 75 (11.1) | 54 (9.9) | 21 (15.8) |
 Urinary tract | 335 (49.6) | 282 (51.9) | 53 (39.9) |
 Intra-abdomen | 182 (26.9) | 143 (26.3) | 39 (29.3) |
 Pulmonary | 7 (1.0) | 2 (0.4) | 5 (3.8) |
 Others | 23 (3.3) | 17 (3.1) | 5 (3.8) |
 Unknown | 55 (8.1) | 45 (8.3) | 10 (7.5) |
Neutropeniaa | 25 (3.7) | 18 (3.3) | 7 (5.3) |
Hospital days, median (range) | 15 (0–159) | 14 (0–157) | 18 (0–159) |